Magentiq Eye vs Tempus AI Imaging

openFDA shows four MAGENTIQ-COLO decisions under product code QNP, from K223473 on July 25, 2023 to K260724 on April 3, 2026. The vendor describes upper-GI landmark detection and Mayo score tracking for ulcerative colitis as upcoming and not yet cleared. Magentiq sells to GI groups that want polyps flagged live, with size and type shown on screen.

Tempus Pixel began as Arterys, which Tempus acquired on October 3, 2022, and Arterys, Inc. is still the applicant on K252539 (September 3, 2025). Radiology and oncology services buy it for lesion tracking with RECIST-style reports, plus cardiac MR analysis. The radiology page footnote says Pixel Lung, cleared as K203744, is not indicated for lung nodule detection, so US nodule detection comes from third-party engines such as InferRead CT. The vendor claims 100+ health systems, and its radiology page says Pixel integrates with PACS, EHR, worklist, notification and dictation systems without naming vendors.